Home/Filings/4/0001209191-17-063403
4//SEC Filing

GREGOIRE DANIEL N 4

Accession 0001209191-17-063403

CIK 0000019411other

Filed

Dec 3, 7:00 PM ET

Accepted

Dec 4, 11:52 AM ET

Size

13.4 KB

Accession

0001209191-17-063403

Insider Transaction Report

Form 4
Period: 2017-12-01
GREGOIRE DANIEL N
General Counsel and Secretary
Transactions
  • Sale

    Ordinary Common Stock, $0.01 par value

    2017-12-01$89.08/sh8,275$737,13713,457 total
  • Exercise of In-Money

    Ordinary Common Stock, $0.01 par value

    2017-12-01$64.87/sh+5,042$327,07521,732 total
  • Exercise of In-Money

    Stock Options (right to buy)

    2017-12-015,04210,083 total
    Exercise: $64.87Exp: 2026-03-03Common Stock (5,042 underlying)
  • Exercise of In-Money

    Stock Options (right to buy)

    2017-12-013,23312,538 total
    Exercise: $63.95Exp: 2025-03-04Common Stock (3,233 underlying)
  • Exercise of In-Money

    Ordinary Common Stock, $0.01 par value

    2017-12-01$63.95/sh+3,233$206,75016,690 total
Footnotes (5)
  • [F1]This transaction was effectuated pursuant to a Rule 10b-5-1 Plan.
  • [F2]The number of securities reported represents an aggregate number of shares sold in multiple open market transactions at prices ranging from $88.50 to $90.30, inclusive. The price reported represents the weighted average price. The Reporting Person undertakes to provide staff of the SEC, the issuer, or a stockholder of the issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
  • [F3]The remainder of 12,538 options shall vest on March 4, 2018.
  • [F4]Not applicable.
  • [F5]The remainder of 10,083 options shall vest in equal increments on March 3 of 2018 and 2019.

Issuer

MAGELLAN HEALTH INC

CIK 0000019411

Entity typeother

Related Parties

1
  • filerCIK 0001184746

Filing Metadata

Form type
4
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 11:52 AM ET
Size
13.4 KB